DPIIT recognised startup Government of India
Startup India
Neuropex Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.55 Cr
▲ 46% YoY
Net profit · FY 2024
₹1.75 Lakh
Net margin 0.7%
EBITDA · FY 2024
₹6.12 Lakh
EBITDA margin 2.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹48 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
11
Provident fund records
About Neuropex Pharmaceuticals Private Limited
Data last updated:
Neuropex Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51900UP2019PTC124277. Its GSTIN is 09AAGCN7872A1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ajay Mishra and Neha Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.55 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹1.75 Lakh (net margin 0.7%) and EBITDA of ₹6.12 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹48 Lakh on record.
Neuropex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0061185). For more details, the company can be reached via its website neuropex.in.
Company details
CIN U51900UP2019PTC124277
Registration Number 124277
Incorporation Date 09 December 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0061185
Recognitions & Rankings of Neuropex Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0061185
Contact details
Neuropex Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is neuropex.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 10 Gata No 374/2 Navikot Nandana, Bakshi Ka Talab, Lucknow, Uttar Pradesh, India – 226021
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neuropex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neuropex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neuropex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neuropex Pharmaceuticals Private Limited, buy the company report.
Financials of Neuropex Pharmaceuticals Private Limited
FY 2024 filings availableNeuropex Pharmaceuticals Private Limited reported revenue of ₹2.55 Cr (up 46% YoY) for FY 2024.
Revenue · FY 2024
₹2.55 Cr ▲ 46%
Net profit · FY 2024
₹1.75 Lakh margin 0.7%
EBITDA · FY 2024
₹6.12 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 104%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 99%
Revenue has grown at a compounded annual rate (CAGR) of 104% over three years, including 46% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neuropex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neuropex Pharmaceuticals Private Limited
Neuropex Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Mishra | Director | 09 Dec 2019 | 6 Years 10 Months | Current |
| Neha Agarwal | Director | 09 Dec 2019 | 6 Years 10 Months | Current |
| Rohit Khanna | Director | 09 Dec 2019 | 6 Years 10 Months | Current |
Auditor
Neuropex Pharmaceuticals Private Limited is audited by SETH CHATURVEDI & JAIN for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SETH CHATURVEDI & JAIN | FY 2020 | 004537C |
Shareholding
The shareholding of Neuropex Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Neuropex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹48 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2024 | 101001751 | Axis Bank Limited | ₹48 Lakh | Open |
To see the full charge records of Neuropex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neuropex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neuropex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neuropex Pharmaceuticals Private Limited has a workforce of 11 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
11
Active EPFO establishments
1
Employee growth
57.14%
GST
Neuropex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN7872A1ZB | Uttar Pradesh | Active | 24 Dec 2019 |
To see the full GST registrations and return filing status of Neuropex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neuropex Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Ajay Mishra was appointed as Director on 09 Dec 2019.
AGM
Neuropex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 48.00 Lakh registered on 07 Sep 2024 with Charge ID 101001751 was modified on 09 Jul 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 48.00 Lakh with Charge ID 101001751 was registered on 07 Sep 2024.
Filing
Neuropex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttar Pradesh I.
Appointed
Ajay Mishra was appointed as Director.
Appointed
Neha Agarwal was appointed as Director.
Appointed
Rohit Khanna was appointed as Director.
Incorporation
09 Dec 2019
Neuropex Pharmaceuticals Private Limited was registered on 09 Dec 2019 with Roc Uttar Pradesh I & aged 6 years 10 months as per MCA records.
Frequently asked questions
Neuropex Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 December 2019 (7+ years old) and is registered under CIN U51900UP2019PTC124277.
Neuropex Pharmaceuticals has 3 current directors:
- Ajay Mishra - Director
- Neha Agarwal - Director
- Rohit Khanna - Director
The latest financial statements of Neuropex Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Neuropex Pharmaceuticals is 09AAGCN7872A1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Neuropex Pharmaceuticals is U51900UP2019PTC124277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neuropex Pharmaceuticals was incorporated on 09 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ajay Mishra was appointed as Director on 09 Dec 2019. Neha Agarwal was appointed as Director on 09 Dec 2019. Rohit Khanna was appointed as Director on 09 Dec 2019.
Yes, Neuropex Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Neuropex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0061185).
Neuropex Pharmaceuticals can be reached through the website neuropex.in. Its registered office is in Lucknow, Uttar Pradesh, India.